E1	Age:T1 Eq-Comparison:E2
E2	Eq-Comparison:T2 Operator:T104 Value:T105 Temporal-Unit:T106
E3	Modifier:T3 Modifies:T108
E4	Or:T4 Arg:E3 Arg2:E5
E5	Procedure:T5 Name:T107
E6	Condition:T6 Name:T108
E7	Modifier:T7 Modifies:T108
E8	Or:T8 Arg:E7 Arg2:E9
E9	Modifier:T9 Modifies:T108
E10	Procedure:T10 Name:T109
E11	Condition:T11 Name:T110
E12	Temporal-Connection:T12 Arg:E11 Arg2:E13
E13	Eq-Comparison:T13 Temporal-Period:T111
E14	Procedure:T14 Temporality:E13
E15	Modifier:T15 Modifies:T113
E16	Or:T16 Arg:E15 Arg2:E17
E17	Modifier:T17 Modifies:T113
E18	Drug:T18 Name:T113
E19	Drug:T19 Name:T114
E20	Or:T20 Arg:E19 Arg2:E21
E21	Drug:T21 Name:T115
E22	Condition:T22 Name:T116 Polarity:T117
E23	Temporal-Connection:T23 Arg:E22 Arg2:E24
E24	Condition:T24 Name:T118
E25	Eq-Comparison:T25 Temporal-Period:T119
E26	Drug:T26 Temporality:E25 Name:T172
E27	Observation:T27 Name:T120
E28	Observation:T28 Name:T121 Eq-Comparison:E29
E29	Eq-Comparison:T29 Value:T122 Operator:T123 Value2:T124
E30	Observation:T30 Name:T126 Eq-Comparison:E31
E31	Eq-Comparison:T31 Value:T127 Temporal-Unit:T128 Operator:T125
E32	Eq-Comparison:T32 Operator:T129 Value:T130
E33	Condition:T33 Name:T131 Minimum-Count:E32
E34	Negation:T34 Negates:E36
E35	Eq-Comparison:T35 Temporal-Period:T132
E36	Procedure:T36 Name:T173 Temporality:E35
E37	Temporal-Connection:T37 Arg:E36 Arg2:E38
E38	Study:T38 
E40	Assertion:T40 Asserted:E39
E41	Temporal-Connection:T41 Arg:E39 Arg2:E42
E42	Study:T42 
E43	Assertion:T43 Asserted:E44
E44	Procedure:T44 Name:T176
E45	Temporal-Connection:T45 Arg:E44 Arg2:E46
E46	Study:T46 
E47	And:T47 Arg:E46 Arg2:E48
E48	Eq-Comparison:T48 Operator:T133 Value:T134 Temporal-Unit:T135
E49	Temporal-Connection:T49 Arg:E48 Arg2:E50
E50	Eq-Comparison:T50 Temporal-Recency:T136
E52	Condition:T52 Name:T137 Temporality:E50
E53	Assertion:T53 Asserted:E51
E54	Condition:T54 Name:T139
E55	Observation:T55 Name:T141 Polarity:T140
E56	Or:T56 Arg:E51 Arg2:E57
E57	Negation:T57 Negates:E58
E58	Condition:T58 Name:T142
E59	Procedure:T59 
E60	Modifier:T60 Modifies:T143
E61	Or:T61 Arg:E60 Arg2:E62
E62	Modifier:T62 Modifies:T143
E63	Drug:T63 Name:T143 Temporality:E64
E64	Eq-Comparison:T64 Operator:T144 Value:T145 Temporal-Unit:T146
E65	Temporal-Connection:T65 Arg:E64 Arg2:E66
E66	Study:T66 
E68	Eq-Comparison:T68 Temporal-Period:T147
E69	Procedure:T69 Temporality:E68
E71	Drug:T71 Name:T148
E72	Eq-Comparison:T72 Temporal-Period:T70
E73	Condition:T73 Name:T149 Temporality:E72
E74	Eq-Comparison:T74 Temporal-Period:T150
E75	Procedure:T75 Name:T151 Temporality:E74
E77	Condition:T77 Name:T152 Stability:T76
E78	Or:T78 Arg:E77 Arg2:E80
E79	Modifier:T79 Modifies:T153
E80	Condition:T80 Name:T153
E81	Or:T81 Arg:T154 Arg2:E82
E82	Modifier:T82 Modifies:T155
E84	Condition:T84 Name:T155 Severity:T154
E85	Modifier:T85 Modifies:T156
E86	Condition:T86 Name:T156
E87	Condition:T87 Name:T157
E89	Or:T89 Arg:E87 Arg2:E90
E90	Condition:T90 Name:T158
E91	Eq-Comparison:T91 Unit:T178 Operator:T159 Value:T177
E92	Temporal-Connection:T92 Arg:E70 Arg2:E93
E93	Study:T93 
E94	Condition:T94 Name:T161 Severity:T160
E95	Condition:T95 Name:T162
E96	Condition:T96 Name:T164 Severity:T163
E97	Condition:T97 Name:T165
E98	Eq-Comparison:T98 Temporal-Period:T166
E99	Procedure:T99 Minimum-Count:E100
E100	Eq-Comparison:T100 Value:T167 Operator:T168
E101	Procedure:T101 Name:T169
E102	Or:T102 Arg:E101 Arg2:E103
E103	Procedure:T103 Name:T170
E104	Modifier:T112 Modifies:E14
E105	Temporal-Connection:T171 Arg:E24 Arg2:E25
E39	Observation:T39 Name:T174
E106	And:T175 Arg:E38 Arg2:E40
E51	Negation:T51 Negates:E54
E67	Modifier:T67 Modifies:T148
E70	Observation:T83 Name:T88 Eq-Comparison:E91
T1	Age 25 29	Aged
T2	Eq-Comparison 30 47	at least 18 years
T3	Modifier 54 68	Histologically
T4	Or 69 71	or
T5	Procedure 72 85	cytologically
T6	Condition 106 111	NSCLC
T7	Modifier 120 136	locally advanced
T8	Or 137 139	or
T9	Modifier 140 150	metastatic
T10	Procedure 157 169	Radiological
T11	Condition 187 206	disease progression
T12	Temporal-Connection 207 212	while
T13	Eq-Comparison 218 226	previous
T14	Procedure 238 247	treatment
T15	Modifier 256 261	first
T16	Or 262 264	or
T17	Modifier 265 282	second generation
T18	Drug 286 294	EGFR TKI
T19	Drug 300 309	gefitinib
T20	Or 310 312	or
T21	Drug 313 322	erlotinib
T22	Condition 369 390	tumour T790M mutation
T23	Temporal-Connection 419 424	after
T24	Condition 425 444	disease progression
T25	Eq-Comparison 452 457	prior
T26	Drug 458 466	EGFR TKI
T27	Observation 473 526	Eastern cooperative oncology group performance status
T28	Observation 528 532	ECOG
T29	Eq-Comparison 540 543	0-1
T30	Observation 560 575	life expectancy
T31	Eq-Comparison 579 587	12 weeks
T32	Eq-Comparison 594 606	At least one
T33	Condition 607 613	lesion
T34	Negation 615 618	not
T35	Eq-Comparison 619 629	previously
T36	Procedure 630 640	irradiated
T37	Temporal-Connection 641 647	during
T38	Study 652 657	study
T40	Assertion 681 687	can be
T41	Temporal-Connection 708 710	at
T42	Study 711 719	baseline
T43	Assertion 750 758	Agree to
T44	Procedure 794 807	contraceptive
T45	Temporal-Connection 817 823	during
T46	Study 835 840	study
T47	And 848 851	and
T48	Eq-Comparison 852 866	within 6 weeks
T49	Temporal-Connection 867 872	after
T50	Eq-Comparison 877 881	last
T52	Condition 887 911	pre-menopausal fertility
T53	Assertion 938 945	need to
T54	Condition 954 963	pregnancy
T55	Observation 977 991	pregnancy test
T56	Or 993 996	and
T57	Negation 1000 1003	non
T58	Condition 1004 1013	lactation
T59	Procedure 1047 1056	Treatment
T60	Modifier 1064 1069	first
T61	Or 1070 1072	or
T62	Modifier 1073 1090	second generation
T63	Drug 1094 1102	EGFR-TKI
T64	Eq-Comparison 1103 1116	within 7 days
T65	Temporal-Connection 1117 1119	of
T66	Study 1120 1125	study
T68	Eq-Comparison 1133 1141	previous
T69	Procedure 1142 1151	treatment
T71	Drug 1179 1187	EGFR-TKI
T72	Eq-Comparison 1194 1204	Unresolved
T73	Condition 1205 1215	toxicities
T74	Eq-Comparison 1221 1226	prior
T75	Procedure 1227 1234	therapy
T77	Condition 1250 1273	spinal cord compression
T78	Or 1273 1274	/
T79	Modifier 1274 1279	brain
T80	Condition 1280 1290	metastases
T81	Or 1303 1304	/
T82	Modifier 1304 1325	uncontrolled systemic
T84	Condition 1326 1334	diseases
T85	Modifier 1346 1358	uncontrolled
T86	Condition 1359 1371	hypertension
T87	Condition 1373 1391	bleeding diatheses
T89	Or 1392 1394	or
T90	Condition 1395 1404	infection
T91	Eq-Comparison 1415 1424	>470 msec
T92	Temporal-Connection 1425 1431	during
T93	Study 1436 1445	screening
T94	Condition 1466 1486	respiratory diseases
T95	Condition 1495 1520	interstitial lung disease
T96	Condition 1529 1535	asthma
T97	Condition 1537 1555	pulmonary embolism
T98	Eq-Comparison 1567 1575	previous
T99	Procedure 1576 1585	treatment
T100	Eq-Comparison 1591 1600	2 or more
T101	Procedure 1610 1622	Chemotherapy
T102	Or 1623 1625	or
T103	Procedure 1626 1639	immunotherapy
T104	Eq-Operator 30 38	at least
T105	Eq-Value 39 41	18
T106	Eq-Temporal-Unit 42 47	years
T107	Procedure-Name 72 85	cytologically
T108	Condition-Name 106 111	NSCLC
T110	Condition-Name 187 206	disease progression
T111	Eq-Temporal-Period 218 226	previous
T113	Drug-Name 286 294	EGFR TKI
T114	Drug-Name 300 309	gefitinib
T115	Drug-Name 313 322	erlotinib
T116	Condition-Name 369 390	tumour T790M mutation
T117	Polarity 409 417	positive
T118	Condition-Name 425 444	disease progression
T119	Eq-Temporal-Period 452 457	prior
T120	Observation-Name 473 526	Eastern cooperative oncology group performance status
T121	Observation-Name 528 532	ECOG
T122	Eq-Value 540 541	0
T123	Eq-Operator 541 542	-
T124	Eq-Value 542 543	1
T125	Eq-Operator 552 559	minimum
T126	Observation-Name 560 575	life expectancy
T127	Eq-Value 579 581	12
T128	Eq-Temporal-Unit 582 587	weeks
T129	Eq-Operator 594 602	At least
T130	Eq-Value 603 606	one
T131	Condition-Name 607 613	lesion
T132	Eq-Temporal-Period 619 629	previously
T133	Eq-Operator 852 858	within
T134	Eq-Value 859 860	6
T135	Eq-Temporal-Unit 861 866	weeks
T136	Eq-Temporal-Recency 877 881	last
T137	Condition-Name 887 911	pre-menopausal fertility
T138	Life-Stage-And-Gender 922 928	Female
T139	Condition-Name 954 963	pregnancy
T140	Polarity 968 976	negative
T141	Observation-Name 977 991	pregnancy test
T142	Condition-Name 1004 1013	lactation
T143	Drug-Name 1094 1102	EGFR-TKI
T144	Eq-Operator 1103 1109	within
T145	Eq-Value 1110 1111	7
T146	Eq-Temporal-Unit 1112 1116	days
T147	Eq-Temporal-Period 1133 1141	previous
T148	Drug-Name 1179 1187	EGFR-TKI
T149	Condition-Name 1205 1215	toxicities
T150	Eq-Temporal-Period 1221 1226	prior
T151	Procedure-Name 1227 1234	therapy
T152	Condition-Name 1250 1273	spinal cord compression
T153	Condition-Name 1280 1290	metastases
T154	Severity 1297 1303	Severe
T155	Condition-Name 1326 1334	diseases
T156	Condition-Name 1359 1371	hypertension
T157	Condition-Name 1373 1391	bleeding diatheses
T158	Condition-Name 1395 1404	infection
T160	Severity 1459 1465	Severe
T161	Condition-Name 1466 1486	respiratory diseases
T162	Condition-Name 1495 1520	interstitial lung disease
T163	Severity 1522 1528	severe
T164	Condition-Name 1529 1535	asthma
T165	Condition-Name 1537 1555	pulmonary embolism
T166	Eq-Temporal-Period 1567 1575	previous
T167	Eq-Value 1591 1592	2
T168	Eq-Operator 1593 1600	or more
T169	Procedure-Name 1610 1622	Chemotherapy
T170	Procedure-Name 1626 1639	immunotherapy
T109	Procedure-Name 157 169	Radiological
T112	Modifier 227 237	continuous
T171	Temporal-Connection 445 447	on
T172	Drug-Name 458 466	EGFR TKI
T173	Procedure-Name 630 640	irradiated
T39	Observation 699 707	measured
T174	Observation-Name 699 707	measured
T175	And 676 680	that
T176	Procedure-Name 794 807	contraceptive
T51	Negation 946 953	exclude
T67	Modifier 1159 1175	third generation
T70	Eq-Temporal-Period 1194 1204	Unresolved
T76	Stability 1241 1249	Unstable
T83	Observation 1411 1415	QTcF
T88	Observation-Name 1411 1415	QTcF
T159	Eq-Operator 1415 1416	>
T177	Eq-Value 1416 1419	470
T178	Eq-Unit 1420 1424	msec
A1	Temporal-Connection-Type-Value E12 during
A2	Temporal-Connection-Type-Value E23 after
A3	Temporal-Connection-Type-Value E37 during
A4	Assertion-Type-Value E40 hypothetical
A5	Temporal-Connection-Type-Value E41 during
A6	Assertion-Type-Value E43 hypothetical
A7	Temporal-Connection-Type-Value E45 during
A8	Temporal-Connection-Type-Value E49 after
A10	Assertion-Type-Value E53 hypothetical
A11	Temporal-Connection-Type-Value E65 before
A12	Temporal-Connection-Type-Value E92 during
A13	Eq-Operator-Value T104 GTEQ
A14	Eq-Temporal-Unit-Value T106 year
A15	Eq-Temporal-Period-Value T111 past
A17	Polarity-Value T117 positive
A18	Eq-Temporal-Period-Value T119 past
A19	Observation-Type-Value T120 clinical-score
A20	Eq-Operator-Value T123 BETWEEN
A21	Eq-Operator-Value T125 GTEQ
A22	Eq-Temporal-Unit-Value T128 week
A23	Eq-Operator-Value T129 GTEQ
A24	Eq-Temporal-Period-Value T132 past
A25	Eq-Operator-Value T133 LTEQ
A26	Eq-Temporal-Unit-Value T135 week
A28	Life-Stage-And-Gender-Type T138 female
A29	Polarity-Value T140 negative
A30	Observation-Type-Value T141 lab
A31	Eq-Operator-Value T144 LTEQ
A32	Eq-Temporal-Unit-Value T146 day
A33	Eq-Temporal-Period-Value T147 past
A34	Eq-Temporal-Period-Value T150 past
A35	Severity-Value T154 severe
A36	Severity-Value T160 severe
A37	Severity-Value T163 severe
A38	Eq-Temporal-Period-Value T166 past
A39	Eq-Operator-Value T168 GTEQ
A16	Temporal-Connection-Type-Value E105 during
A40	Observation-Type-Value T174 measurement
A27	Eq-Temporal-Recency-Value T136 most-recent-time
A9	Eq-Temporal-Period-Value T70 present
A41	Stability-Value T76 change
A42	Observation-Type-Value T88 measurement
A43	Eq-Operator-Value T159 GT
R1	Found-By Arg1:E6 Arg2:E5
R2	Found-By Arg1:E11 Arg2:E10
R3	Example-Of Arg1:E19 Arg2:E18
R4	Example-Of Arg1:E21 Arg2:E19
R5	Using Arg1:E14 Arg2:E18
R6	Abbrev-Of Arg1:E28 Arg2:E27
R7	If-Then Arg1:T138 Arg2:E53
R8	Equivalent-To Arg1:E55 Arg2:E51
R9	Using Arg1:E59 Arg2:E63
R10	Using Arg1:E69 Arg2:E71
R11	Caused-By Arg1:E73 Arg2:E75
R12	Example-Of Arg1:E86 Arg2:E84
R13	Example-Of Arg1:E87 Arg2:E84
R14	Example-Of Arg1:E90 Arg2:E84
R15	Example-Of Arg1:E95 Arg2:E94
R16	Example-Of Arg1:E96 Arg2:E94
R17	Example-Of Arg1:E97 Arg2:E94
R18	Equivalent-To Arg1:E99 Arg2:E98
R19	Using Arg1:E99 Arg2:E101
R20	Using Arg1:E99 Arg2:E103
